Analysts and calls -- SG Cowen Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Analysts and calls -- SG Cowen

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

To: Icebrg who wrote (2)	7/4/2003 3:23:47 AM
From: Icebrg	of 3

Cephalon "strong buy" Thursday, July 03, 2003 10:39:00 AM ET SG Cowen NEW YORK, July 3 (New Ratings) – Analyst Schmidt of SG Cowen issues a "strong buy" rating on Cephalon (CEPH). In a research note published this morning, the analyst mentions that the current prescription trends for three of the company’s products, Provigil, Actiq and Gabitril, are encouraging. The analysts say that Cephalon’s robust top-line and EPS growth are expected to enable the company to outperform its peers in the near-term.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext